The future of the global diagnostic imaging market looks promising with opportunities in the public hospital and private hospital & imaging center markets.
- Within the type category, x-ray systems is expected to witness higher growth over the forecast period due to the increasing demand for rapid diagnostic imaging procedures.
- Within the end use category, private hospitals & imaging centers is expected to witness higher growth over the forecast period due to the rising patient volume requiring advanced diagnostic imaging services.
- In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the expanding healthcare infrastructure increasing diagnostic equipment adoption.
Emerging Trends in Diagnostic Imaging Market
The diagnostic imaging market will be transitioning from equipment sales toward connected, AI-based diagnostic pathways from 2025-2027. Hospitals are focused on workflow to increase throughput and decrease patient radiation exposure. Outpatient facilities are focused on increasing patient access. Lucintel predicts that manufacturers will focus on workflow to gain competitive edge rather than scanner sales.- AI-enabled Interpretation: The FDA has been increasingly approving various AI software for use in radiology. As of 2024, there were over 1,000 AI-based medical devices with the agency. In 2025, procurement of these devices will be based on measured reduction of reporting times. In the next 3-5 years, it will be commonplace for workflow to be enabled by AI rather than rely on software for image interpretation.
- Outpatient Migration: U.S. providers continued moving imaging to lower-cost, higher-volume ambulatory centers in 2025, with Medicare’s 2025 payment framework also incentivizing use of outpatient diagnostic services. This shift will benefit vendors with compact systems, remote reading capabilities, and high equipment utilization.
- Lower Dose and Spectral Imaging: In 2025, CT manufacturers plan to launch models that integrate photon-counting and spectral detection, and reduce effective doses without compromising image quality. Tissue characterization and lower radiation doses will gain in importance as imaging plays a larger role in screening for cardiac and oncologic diseases and in other emergency situations.
- Automation: The integration of imaging systems with equipment to automate appointment scheduling, protocol selection, image reconstruction, and report generation, is becoming commonplace, especially in systems where multiple examinations are required. Over the next 3-5 years, automation will likely be a procurement requirement to address equipment utilization and throughput.
- Service-based Purchasing: Long-term, predictable capital spending by hospitals is fueling a shift toward service-based procurement contracts. Vendor programs integrating service-based contracts with hardware and software updates should allow hospitals to focus on clinical productivity and uptime.
Recent Developments in the Diagnostic Imaging Market
The diagnostic imaging market Has Shifted Toward Faster, Software-based Growth, and During The 2025-2027 Period, Hospitals Have Focused on Relief Cycles, Replacements, and AI in Workflow. Lucintel's Market View Aligns with Trends in The Marketplace: Active investment continues, but adoption is constrained by reimbursement, workforce shortages and procurement.- Digital Imaging Acquisitions: In January 2025, GE HealthCare completed its $2.3 billion acquisition of Intelerad, adding cloud-based enterprise imaging and workflow solutions to GE’s portfolio. Expect consolidation in the market and increased platform selling in the next 3 to 5 years, leaving hospitals fewer and more integrated technology options.
- AI Workflow Partnerships: In June 2025, GE HealthCare and NVIDIA expanded their collaboration in imaging to include use of generative AI for over 20 medical procedures. Agreements like these change the competitive landscape from differentiating hardware to productive comparisons in areas such as speed of reporting and clinical decision making.
- Investments in Production: In February 2025, Siemens Healthineers announced approximately €200 million in additional investments for their production and R&D facilities in Bengaluru, India. It will shorten their supply chains, help better meet the needs of the fast-growing markets in the region, and reduce their dependency on shipments from North America and Europe.
- FDA Approvals: By August 2025, the U.S. Food and Drug Administration (FDA) cleared more than 1,000 AI medical devices, the largest share of which are in the field of radiology. Faster review times at the FDA increase the number of devices in the pipeline. While this facilitates purchase decisions for hospitals, greater emphasis will be placed on the safety, workflow integration, and economic value of the devices.
- Access Models: United Imaging continues efforts to commercialize their MRI and CT scanners by using capital- and service-light access models. As part of these models, United Imaging secured multiple multi-year contracts to provide equipment worth over $100 million. These models should increase the use of advanced imaging in areas of the world where the capital and radiologist resources are limited.
Strategic Growth Opportunities in the Diagnostic Imaging Market
Diagnostic imaging market is entering an active period from 2024 to 2026 as there is a convergence of factors including an aging population, delayed diagnoses, and the need for cancer screening and imaging, and replacement of old equipment. Hospitals also are under pressure to reduce the cost and increase the efficiency of procedures while also dealing with staffing shortages. Lucintel sees opportunity in the market for solutions to improve efficiency and productivity as well as confidence in clinical diagnosis and the economics of equipment in the healthcare industry.- Point-of-care Imaging: Compact and portable systems allow imaging to occur at or near the location of patient care. Handheld and compact ultrasound devices provide a wide variety of clinical and emergency imaging. In January 2025, Philips reported strong growth of its handheld ultrasound business. Decentralized care will change equipment purchasing outside the radiology departments in the next 3 to 5 years.
- AI-enabled Workflow Software: There will be a shift to recurring software that prioritizes studies, identifies abnormalities and reduces reporting delays. The FDA announced in March 2025 that more than 1,000 AI-enabled medical devices had been authorized, including many within radiology. AI will be funded by hospitals when meaningful productivity gains offset the shortage of radiologists and increasing volume of diagnostic studies.
- Premium Oncology Imaging: The share of hybrid systems, which integrate functional and anatomical information, will increase for oncology imaging for staging and planning of treatments, as well as monitoring of response to therapy. In June 2025, Siemens Healthineers, stated that the demand for PET/CT was increasing across the oncology value chain. The need for higher-value clinical decisions will create a premium and a replacement demand for the next 10 years.
- Emerging Market Capacity: There is growing demand for MRI and CT systems in private diagnostic networks and public health programs, especially in Southeast Asia, the Middle East and Africa. In February 2025, the budget for the Indian health sector was set at ₹99,858 crore. In areas where the referral and specialist care access are limited, local models of service and financing will speed the installation of imaging equipment.
- Sustainable Imaging Operations: There will be a greater emphasis on lower energy consumption, longer component life, refurbishment and remote monitoring of imaging equipment. In April 2025, the NHS announced a target of net-zero emissions by 2040. Standards and procurement policies will dictate the energy consumption and lifecycle costs of medical equipment and create aftermarket opportunities.
Diagnostic Imaging Market Drivers and Challenges
Different trends influence the diagnostic imaging market in different ways. For example, there are the global economic conditions, the pace of advancement in technology, regulations, and demographics. Factors such as Artificial Intelligence, a growing and aging population, and the expanding infrastructure of the healthcare industry are creating a greater demand for diagnostic imaging. Market challenges such as declining reimbursement and equipment costs, the high cost of imaging equipment, data security, and an increasing shortage of qualified healthcare professionals, make it difficult to incorporate the latest diagnostic imaging technology. Market potential is mostly dependent on balancing innovations and affordability, as well as adhering to regulations. Lucintel states that ensuring timely access to medical imaging is imperative to increase the health equity and outcomes in the world’s population.The factors responsible for driving this market include:
- Increase in Chronic Disease Burden: The growing incidences of cancers, cardiovascular diseases, neurological disorders, and orthopedic diseases have increased the demand for CT, MRI, ultrasound and X-ray examinations. The International Diabetes Federation has estimated that in 2.02 trillion adults were living with diabetes, thus boosting the need for continuous diagnostic monitoring (December 2025). Over the next 3 to 5 years, the same trends will be driven by an aging population, along with the expansion of screening and preventive programs. Increased demand for diagnostic imaging leads to improved diagnosis, prevention and treatment of chronic conditions. As a result, health care providers are more inclined to invest in advanced and high-speed diagnostic imaging systems.
- Integration of Artificial Intelligence: AI is being increasingly integrated in multiple imaging processes like improvement of image reconstruction, triage, lesion detection, workflow, scheduling, and report writing. The United States Food and Drug Administration (FDA) approved more than 1,000 artificial intelligence (AI) medical devices by August 2024, with the largest number in the field of radiology, thus creating an excellent basis for rapid adoption in the coming years. In the next 3 to 5 years, AI will shape the market by automating and improving the quality and consistency of image interpretation. The greatest impact of AI is likely in the region of the world with the greatest demand for diagnostic imaging and interpretation.
- Advanced Imaging Innovation: Improvements in imaging technologies, including the development of lower dose CT, higher field MRI, portable ultrasound, digital radiography, spectral imaging, and hybrid imaging modalities have improved the diagnostic quality and utility of medical imaging. The International Atomic Energy Agency (IAEA) continued its promotion of the optimization of radiation doses, through its global initiatives on the safety of imaging modalities in April 2025. In the next 3 to 5 years, imaging companies will use innovations in portable design to place imaging equipment in more healthcare settings, including rural and emergency care settings.
- Healthcare Infrastructure Expansion: There is increasing public and private investment in a broad array of healthcare facilities, including hospitals, outpatient centers, diagnostic imaging centers, telemedicine and rural healthcare infrastructure. In May 2025, the World Health Organization (WHO) indicated that over 4 billion people do not have essential health and wellness services, including the availability of diagnostic services, thus creating a huge unmet demand for diagnostic capacity. There is a concurrent investment in the broadening of healthcare infrastructure to include remote imaging and diagnostics, as well as broader integrations of imaging services and systems throughout healthcare infrastructure.
- Workflow and Cost Efficiency: Healthcare professionals are leveraging cloud-based technologies to streamline picture archiving, remote radiology, and automated protocols to mitigate increases in examination volumes and operating costs. For the European Union, January 2025, represented the first full application of some provisions of the Artificial Intelligence Act, creating more regulatory scrutiny on clinical software. In the coming years, the focus will be on workflow rather than cost. The main drivers will be improved scanner utilization and throughput, reduced repeat exams, and more efficient reporting. In outpatient settings and other resource-restricted environments, cost will remain a major factor.
The challenges facing this market include:
- High Capital and Operating Costs: Continuous and rapid developments in diagnostic imaging increase capital requirements and costly maintenance of systems, software and staff. High costs of non-labor inputs and a regulated labor market accentuate challenges in the diagnostics sector. In addition to the replacement of older systems, many entities in the healthcare sector are upgrading and expanding to meet increasing patient demand. These costs may result in longer system replacement cycles, especially in smaller hospitals. Shifts toward leased, managed services and shared diagnostics will be observed. Manufacturers will be pressed to differentiate based on clinical and economic outcomes.
- Regulatory and Data Privacy Complexity: As more AI and cloud connectivity are incorporated into imaging systems, additional complexities such as validations, cyber security, consents, interoperability, and cross-border data protections, would also apply. The European Union’s Artificial Intelligence Act was implemented in August 2024 and has ongoing requirements that extends to 2025 and 2026. Within the next three to five years, compliance with these laws will require additional time and cost to implement. As governance further improves trust and reduces inappropriate/unsafe deployment of AI-supported diagnosis, it should facilitate improved adoption of responsible AI in diagnosis across hospitals, and other outpatient facilities.
- Workforce Shortages and Inequities: Due to limited healthcare workforce (i.e. radiologists, radiologic technologists, biomedical engineers and administrators), imaging equipment have limited value in many areas. According to the World Health Organization, there will be a shortage of 11 million health workers by 2030 (May 2025).
List of Diagnostic Imaging Market Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies diagnostic imaging market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base.Some of the diagnostic imaging market companies profiled in this report include:
- Siemens Healthcare GmbH
- General Electric Company
- Koninklijke Philips N.V.
- Canon
Diagnostic Imaging Market by Segment
The study includes a forecast for the global diagnostic imaging market by type, end use, and region.Type [Value ($M) from 2019 to 2035]:
- X-ray Systems
- Computed Tomography (CT) Scan Systems
- Magnetic Resonance Imaging (MRI) Systems
- Ultrasound Systems
- Mammography System
- Nuclear Imaging Systems
End Use [Value ($M) from 2019 to 2035]:
- Public Hospitals
- Private Hospitals & Imaging Centers
Region [Value ($M) from 2019 to 2035]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
Country Wise Outlook for the Diagnostic Imaging Market
The diagnostic imaging market has experienced rapid growth driven by technological advancements, increasing healthcare demands, and expanding applications across medical fields. Innovations such as AI integration, improved imaging resolution, and portable devices are transforming diagnostics worldwide. Governments and private sectors are investing heavily to enhance healthcare infrastructure, making advanced imaging more accessible. Regulatory approvals and collaborations are accelerating product launches, while the adoption of digital health solutions is reshaping patient care. These developments reflect a global shift towards more precise, efficient, and patient-centered diagnostic services, with each country adapting to its unique healthcare landscape and technological capabilities.- United States: The US market has seen significant advancements with the integration of artificial intelligence in imaging systems, improving diagnostic accuracy and workflow efficiency. There is a growing adoption of portable and point-of-care imaging devices, especially in outpatient settings. Regulatory bodies like the FDA are approving innovative technologies rapidly, fostering market growth. Additionally, increased investments in healthcare infrastructure and research are driving innovation. Telemedicine integration with diagnostic imaging is expanding access to remote areas, and private sector collaborations are enhancing technological development and deployment.
- China: China’s diagnostic imaging market is rapidly expanding due to government initiatives to upgrade healthcare infrastructure and increase access to advanced diagnostics. The country is witnessing a surge in the adoption of digital and AI-powered imaging solutions, supported by substantial domestic investments. Local manufacturers are gaining prominence through innovative, cost-effective products tailored to regional needs. The government’s focus on healthcare reform and urbanization is fueling demand for advanced imaging modalities like MRI and CT scans. Additionally, China is becoming a hub for research and development, with collaborations between academia and industry accelerating technological progress.
- Germany: Germany’s market is characterized by a strong emphasis on high-quality imaging equipment and technological innovation. The country is a leader in integrating AI and machine learning into diagnostic systems to enhance precision and efficiency. There is a notable shift towards minimally invasive procedures supported by advanced imaging techniques. Germany’s robust healthcare infrastructure and strict regulatory standards ensure high adoption rates of cutting-edge technologies. The focus on sustainability and energy-efficient devices is also prominent. Moreover, collaborations between medical device companies and research institutions are fostering the development of next-generation imaging solutions.
- India: The Indian diagnostic imaging market is experiencing rapid growth driven by increasing healthcare awareness, rising income levels, and government initiatives to improve healthcare access. The adoption of affordable, portable imaging devices is expanding in rural and semi-urban areas. There is a rising demand for advanced imaging modalities like MRI, CT, and ultrasound, supported by a growing private healthcare sector. The government’s Ayushman Bharat scheme and other health programs are boosting infrastructure development. Additionally, local manufacturers are gaining market share by offering cost-effective solutions, and technological adoption is accelerating with the integration of digital health records and tele-radiology services.
- Japan: Japan’s market is characterized by high adoption of advanced imaging technologies, driven by an aging population and increasing prevalence of chronic diseases. The country is focusing on integrating AI and robotics into diagnostic imaging to improve accuracy and reduce workload. There is a strong emphasis on developing compact, energy-efficient devices suitable for Japan’s healthcare settings. Regulatory support and government funding are facilitating innovation and deployment of new technologies. Japan’s healthcare providers are also investing in digital health solutions, including telemedicine and cloud-based imaging systems, to enhance patient care and operational efficiency.
Features of the Global Diagnostic Imaging Market
- Market Size Estimates: diagnostic imaging market size estimation in terms of value ($M).
- Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
- Segmentation Analysis: diagnostic imaging market size by type, end use, and region in terms of value ($M).
- Regional Analysis: diagnostic imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different type, end use, and regions for the diagnostic imaging market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the diagnostic imaging market.- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the diagnostic imaging market by type (x-ray systems, computed tomography (CT) scan systems, magnetic resonance imaging (MRI) systems, ultrasound systems, mammography system, and nuclear imaging systems), end use (public hospitals and private hospitals & imaging centers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
Companies Mentioned
- Siemens Healthcare GmbH
- General Electric Company
- Koninklijke Philips N.V.
- Canon
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.

LOADING...

